DK568586A - EUKARYOTIC FUSION PROTEINS, THEIR PREPARATION AND USE - Google Patents

EUKARYOTIC FUSION PROTEINS, THEIR PREPARATION AND USE

Info

Publication number
DK568586A
DK568586A DK568586A DK568586A DK568586A DK 568586 A DK568586 A DK 568586A DK 568586 A DK568586 A DK 568586A DK 568586 A DK568586 A DK 568586A DK 568586 A DK568586 A DK 568586A
Authority
DK
Denmark
Prior art keywords
fusion proteins
new
preparation
derivs
terminally
Prior art date
Application number
DK568586A
Other languages
Danish (da)
Other versions
DK172064B1 (en
DK568586D0 (en
Inventor
Paul Habermann
Friedrich Wengenmayer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK568586D0 publication Critical patent/DK568586D0/en
Publication of DK568586A publication Critical patent/DK568586A/en
Application granted granted Critical
Publication of DK172064B1 publication Critical patent/DK172064B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Fusion proteins in which the C- or N-terminal essentially corresponds to the first 100 units of interleukin 2 are new. Also new are gene structures coding for the above fusion proteins, vectors containing these gene structures, and hot cells containing these vectors. Hirudin derivs. with an amino acide sequence begining N-terminally with Pro are new and claimed. Human interleukin 2 derivs. contg. Asp. C-terminally are new and claimed.
DK568586A 1985-11-27 1986-11-26 Fusion protein, its preparation and use, gene structure encoding the fusion protein, vector containing the gene structure, and host cell containing the vector DK172064B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853541856 DE3541856A1 (en) 1985-11-27 1985-11-27 EUKARYOTIC FUSION PROTEINS, THEIR PRODUCTION AND USE, AND MEANS FOR CARRYING OUT THE PROCESS
DE3541856 1985-11-27

Publications (3)

Publication Number Publication Date
DK568586D0 DK568586D0 (en) 1986-11-26
DK568586A true DK568586A (en) 1987-05-28
DK172064B1 DK172064B1 (en) 1997-10-06

Family

ID=6286938

Family Applications (2)

Application Number Title Priority Date Filing Date
DK568586A DK172064B1 (en) 1985-11-27 1986-11-26 Fusion protein, its preparation and use, gene structure encoding the fusion protein, vector containing the gene structure, and host cell containing the vector
DK052292A DK172210B1 (en) 1985-11-27 1992-04-21 hirudin

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK052292A DK172210B1 (en) 1985-11-27 1992-04-21 hirudin

Country Status (17)

Country Link
EP (3) EP0227938B1 (en)
JP (1) JP2566933B2 (en)
KR (1) KR950000300B1 (en)
AT (2) ATE127841T1 (en)
AU (1) AU595262B2 (en)
CA (1) CA1341203C (en)
DE (4) DE3541856A1 (en)
DK (2) DK172064B1 (en)
ES (3) ES2077747T3 (en)
FI (1) FI93471C (en)
GR (1) GR3005042T3 (en)
HU (1) HU203579B (en)
IE (1) IE59488B1 (en)
IL (1) IL80755A0 (en)
NO (1) NO176481C (en)
PT (1) PT83813B (en)
ZA (1) ZA868943B (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125021A (en) * 1955-11-14 1964-03-17 Smooth
ATE64956T1 (en) * 1984-06-14 1991-07-15 Ciba Geigy Ag PROCESS FOR THE PRODUCTION OF THROMBINE INHIBITORS.
DE3712985A1 (en) * 1987-04-16 1988-11-03 Hoechst Ag BIFUNCTIONAL PROTEINS
DE3545568A1 (en) * 1985-12-21 1987-07-16 Hoechst Ag GM-CSF-PROTEIN, ITS DERIVATIVES, PRODUCTION OF SUCH PROTEINS AND THEIR USE
DE3819079A1 (en) * 1988-06-04 1989-12-07 Hoechst Ag HIRUDINE DERIVATIVES WITH DELAYED EFFECT
DE3835815A1 (en) * 1988-10-21 1990-04-26 Hoechst Ag NEW ISOHIRUDINE
DE3844211A1 (en) * 1988-12-29 1990-07-05 Hoechst Ag NEW INSULINE DERIVATIVES, THE PROCESS FOR THEIR PRODUCTION, THEIR USE AND A PHARMACEUTICAL PREPARATION CONTAINING THEM
US5179196A (en) * 1989-05-04 1993-01-12 Sri International Purification of proteins employing ctap-iii fusions
WO1991000912A1 (en) * 1989-07-07 1991-01-24 Massachusetts Institute Of Technology Production and use of hybrid protease inhibitors
CU22222A1 (en) * 1989-08-03 1995-01-31 Cigb PROCEDURE FOR THE EXPRESSION OF HETEROLOGICAL PROTEINS PRODUCED IN A FUSION FORM IN ESCHERICHIA COLI, ITS USE, EXPRESSION VECTORS AND RECOMBINANT STRAINS
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
DE3942580A1 (en) * 1989-12-22 1991-06-27 Basf Ag METHOD FOR PRODUCING HIRUDINE
US5270181A (en) * 1991-02-06 1993-12-14 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
DE4140381A1 (en) * 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De NEW SYNTHETIC ISOHIRUDINE WITH IMPROVED STABILITY
DE4404168A1 (en) * 1994-02-10 1995-08-17 Hoechst Ag Hirudin derivatives and process for their preparation
DE59711533D1 (en) 1996-07-26 2004-05-27 Aventis Pharma Gmbh Insulin derivatives with increased zinc binding
DE19726167B4 (en) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, process for its preparation and pharmaceutical preparation containing it
DE19825447A1 (en) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh New insulin analogues with increased zinc formation
DE10033195A1 (en) * 2000-07-07 2002-03-21 Aventis Pharma Gmbh Bifunctional fusion proteins from hirudin and TAP
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
DE10114178A1 (en) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinc-free and low-zinc insulin preparations with improved stability
DE10227232A1 (en) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Sour insulin preparations with improved stability
EP3228320B1 (en) 2008-10-17 2019-12-18 Sanofi-Aventis Deutschland GmbH Combination of an insulin and a glp-1 agonist
UY33025A (en) 2009-11-13 2011-06-30 Sanofi Aventis Deustschland Gmbh PHARMACEUTICAL COMPOSITION INCLUDING A GLP-1 METIONINE AGONIST
AR080669A1 (en) 2009-11-13 2012-05-02 Sanofi Aventis Deutschland PHARMACEUTICAL COMPOSITION INCLUDING A GLP-1 AGONIST, AN INSULIN AND METIONIN
MX339614B (en) 2010-08-30 2016-06-02 Sanofi - Aventis Deutschland GmbH Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2.
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
RU2650616C2 (en) 2011-08-29 2018-04-16 Санофи-Авентис Дойчланд Гмбх Pharmaceutical combination for use in glycemic control in patients with type 2 diabetes mellitus
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
CN107206058A (en) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 Insulin glargine/lixisenatide fixed ratio preparaton
TWI748945B (en) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 Treatment type 2 diabetes mellitus patients
TW201705975A (en) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 Treatment of type 2 diabetes mellitus patients
KR20200080748A (en) 2018-12-27 2020-07-07 주식회사 폴루스 A Method for Purifying Proinsulin Using Anion Exchange Chromatography
KR20200080747A (en) 2018-12-27 2020-07-07 주식회사 폴루스 An Enzymatic Conversion Composition for Producing Insulin from Proinsulin and a Method for Producing Insulin from Proinsulin Using the Same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000817A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of interleukin ii
DK108685A (en) * 1984-03-19 1985-09-20 Fujisawa Pharmaceutical Co GROWTH FACTOR I
CA1341417C (en) * 1984-03-27 2003-01-21 Paul Tolstoshev Hirudine-expressing vectors, altered cells, and a process for hirudine preparation
EP0158198A1 (en) * 1984-03-29 1985-10-16 Takeda Chemical Industries, Ltd. DNA and use thereof
DE3429430A1 (en) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt GENE TECHNOLOGICAL METHOD FOR PRODUCING HIRUDINE AND MEANS FOR IMPLEMENTING THIS METHOD
DE3526995A1 (en) * 1985-07-27 1987-02-05 Hoechst Ag FUSION PROTEINS, METHOD FOR THEIR PRODUCTION AND THEIR USE
CA1297003C (en) * 1985-09-20 1992-03-10 Jack H. Nunberg Composition and method for treating animals
US4865974A (en) * 1985-09-20 1989-09-12 Cetus Corporation Bacterial methionine N-terminal peptidase

Also Published As

Publication number Publication date
FI93471C (en) 1995-04-10
ES2032378T3 (en) 1993-02-16
FI864798A0 (en) 1986-11-25
JPS62143696A (en) 1987-06-26
NO176481C (en) 1995-04-12
NO176481B (en) 1995-01-02
IE59488B1 (en) 1994-03-09
GR3005042T3 (en) 1993-05-24
DE3650396D1 (en) 1995-10-19
EP0468539A1 (en) 1992-01-29
CA1341203C (en) 2001-03-13
DE3684892D1 (en) 1992-05-21
FI93471B (en) 1994-12-30
AU6569386A (en) 1987-06-04
ES2073081T3 (en) 1995-08-01
PT83813A (en) 1986-12-01
KR870005098A (en) 1987-06-04
NO864759D0 (en) 1986-11-26
PT83813B (en) 1989-06-30
ATE122397T1 (en) 1995-05-15
DE3650322D1 (en) 1995-06-14
KR950000300B1 (en) 1995-01-13
DK52292A (en) 1992-04-21
DK172064B1 (en) 1997-10-06
EP0464867B1 (en) 1995-05-10
IL80755A0 (en) 1987-02-27
ATE127841T1 (en) 1995-09-15
DK172210B1 (en) 1998-01-05
AU595262B2 (en) 1990-03-29
EP0227938A2 (en) 1987-07-08
ZA868943B (en) 1987-07-29
HU203579B (en) 1991-08-28
DK52292D0 (en) 1992-04-21
EP0468539B1 (en) 1995-09-13
EP0464867A1 (en) 1992-01-08
EP0227938B1 (en) 1992-04-15
EP0227938A3 (en) 1988-11-23
ES2077747T3 (en) 1995-12-01
IE863119L (en) 1987-05-27
DK568586D0 (en) 1986-11-26
JP2566933B2 (en) 1996-12-25
DE3541856A1 (en) 1987-06-04
HUT43642A (en) 1987-11-30
FI864798A (en) 1987-05-28

Similar Documents

Publication Publication Date Title
DK568586A (en) EUKARYOTIC FUSION PROTEINS, THEIR PREPARATION AND USE
ES2130120T3 (en) PROCEDURE FOR THE PREPARATION OF HUMAN DNASE.
BG49941A3 (en) Method for preparing recombinated colonniade stimulating factor- 1
DK382786D0 (en) SURFACTIVE RECOMBINANT ALVEOLAR PROTEIN
NO1994025I1 (en) Human immune (¿) interferon and allelic and redundant variations thereof
DE69022559D1 (en) Expression of the recombinant tumor necrosis factor binding protein I (TBP-I).
UA27706C2 (en) Method of obtaining heterologous polypeptide
FI102075B1 (en) Method for preparing glycosylated or non-glycosylated polypeptide, recombinant nucleic acid and vectors
ATE302275T1 (en) HEMATOPOIETIC FUSION PROTEIN MULTIVARIANT CONTAINING IL-3
ES8704207A1 (en) Rhinovirus strain HRV2 polypeptides and DNA molecules encoding them.
ATE402995T1 (en) ACT-3 NUCLEIC ACID, POLYPEPTIDES AND THEIR USE
DE3881023D1 (en) PROTEINS, EXPRESSION VECTORS, CONTAINING DNA ENCODING SUCH PROTEINS, AND CELLS CONTAINING SUCH EXPRESSION VECTORS.
DK288789A (en) PEPTIDES AND ACID ADDITION SALTS THEREOF, THEIR PREPARATION AND USE
ATE85648T1 (en) RECOMBINANT DNA ENCODING A LYTIC ACTIVE CHIMAERIC PROTEIN AND ITS USE.
NO169819C (en) PROCEDURE FOR PREPARING HYBRID POLYPEPTIDE AND DNA MOLECULE FOR USE IN THIS
ES8605296A1 (en) Recominant factor VIII-R.
ES2045004T3 (en) PROCEDURE FOR THE PREPARATION OF EXTRA PROTEINS IN STREPTOMICETS.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired